Covenant Partners, LLC Novartis Ag Transaction History

Covenant Partners, LLC

$337 Million
Q3 2024

A detailed history of Covenant Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Covenant Partners, LLC holds 7,608 shares of NVS stock, worth $793,362. This represents 0.26% of its overall portfolio holdings.

Number of Shares

7,608

Previous 7,542 0.88%

Holding current value

$793,362

Previous $802,000 9.1%

% of portfolio

0.26%

Previous 0.25%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$106.13 - $120.89 $7,004 - $7,978	66 Added 0.88%	7,608 $875,000
Q1 2024 Apr 30, 2024	SELL	$95.27 - $108.47 $29,247 - $33,300	-307 Reduced 3.91%	7,542 $729,000
Q4 2023 Feb 20, 2024	SELL	$92.27 - $101.54 $8,304 - $9,138	-90 Reduced 1.13%	7,849 $792,000
Q3 2023 Oct 20, 2023	SELL	$94.73 - $105.13 $3,410 - $3,784	-36 Reduced 0.45%	7,939 $808,000
Q2 2023 Aug 11, 2023	BUY	$92.52 - $104.91 $11,657 - $13,218	126 Added 1.61%	7,975 $804,000
Q1 2023 Apr 19, 2023	SELL	$80.03 - $92.81 $64,104 - $74,340	-801 Reduced 9.26%	7,849 $722,000
Q4 2022 Feb 17, 2023	SELL	$75.55 - $92.52 $136,669 - $167,368	-1,809 Reduced 17.3%	8,650 $784,000
Q2 2022 Jul 27, 2022	SELL	$80.52 - $93.75 $249,773 - $290,812	-3,102 Reduced 22.87%	10,459 $884,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $196,670 - $222,472	2,455 Added 22.11%	13,561 $1.19 Million
Q4 2021 Feb 15, 2022	SELL	$79.7 - $88.13 $295,607 - $326,874	-3,709 Reduced 25.04%	11,106 $971,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $303,322 - $352,874	3,709 Added 33.4%	14,815 $1.21 Million
Q2 2021 Aug 02, 2021	SELL	$85.24 - $94.15 $279,757 - $309,000	-3,282 Reduced 22.81%	11,106 $1.01 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $389,861 - $459,756	-4,669 Reduced 24.5%	14,388 $1.23 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $706,923 - $855,063	9,055 Added 90.53%	19,057 $1.8 Million
Q3 2020 Nov 10, 2020	BUY	$82.14 - $91.0 $75,404 - $83,538	918 Added 10.11%	10,002 $870,000
Q2 2020 Aug 17, 2020	SELL	$80.93 - $91.1 $121,152 - $136,376	-1,497 Reduced 14.15%	9,084 $793,000
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $273,492 - $383,168	3,870 Added 57.67%	10,581 $872,000
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $443,343 - $501,264	-5,256 Reduced 43.92%	6,711 $635,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $449,598 - $495,430	5,256 Added 78.32%	11,967 $1.04 Million
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $90,630 - $111,545	-1,202 Reduced 15.19%	6,711 $613,000
Q1 2019 May 16, 2019	BUY	$75.32 - $86.15 $138,588 - $158,516	1,840 Added 30.3%	7,913 $761,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $447,337 - $498,107	6,073 New	6,073 $521,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.

Account

Covenant Partners, LLC Novartis Ag Transaction History